Cost concerns, not the guidelines, drive clinical care of IBD during COVID pandemic in a resource limited setting

Expert Rev Gastroenterol Hepatol. 2021 Apr;15(4):465-466. doi: 10.1080/17474124.2021.1890583. Epub 2021 Feb 19.

Authors

Vishal Sharma¹, Jayendra Shukla¹, Vikas Suri², Anuraag Jena¹, Anirudh Mukerjee¹, Harshal S Mandavdhare², Ashish Bhalla², Usha Dutta¹

Affiliations

¹ Department of Gastroenterology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
² Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

PMID: 33576700
DOI: 10.1080/17474124.2021.1890583

No abstract available

Publication types

Letter

MeSH terms

COVID-19* / economics
COVID-19* / epidemiology
Developing Countries* / economics
Developing Countries* / statistics & numerical data
Health Resources / economics
Humans
India / epidemiology
Inflammatory Bowel Diseases* / diagnosis
Inflammatory Bowel Diseases* / economics
Inflammatory Bowel Diseases* / epidemiology
Inflammatory Bowel Diseases* / therapy
Pandemics* / economics
Pandemics* / statistics & numerical data
Practice Guidelines as Topic* / standards
SARS-CoV-2*